| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |